- Home
- SNGX vs WAFU Comparison
SNGX vs WAFU Comparison
Compare SNGX & WAFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- WAFU
- Stock Information
- Founded
- SNGX 1987
- WAFU 1999
- Country
- SNGX United States
- WAFU China
- Employees
- SNGX N/A
- WAFU N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- WAFU Other Consumer Services
- Sector
- SNGX Health Care
- WAFU Real Estate
- Exchange
- SNGX Nasdaq
- WAFU Nasdaq
- Market Cap
- SNGX 6.5M
- WAFU 6.5M
- IPO Year
- SNGX 1987
- WAFU 2019
- Fundamental
- Price
- SNGX $1.28
- WAFU $1.46
- Analyst Decision
- SNGX
- WAFU
- Analyst Count
- SNGX 0
- WAFU 0
- Target Price
- SNGX N/A
- WAFU N/A
- AVG Volume (30 Days)
- SNGX 2.7M
- WAFU 10.4K
- Earning Date
- SNGX 08-08-2025
- WAFU 01-01-0001
- Dividend Yield
- SNGX N/A
- WAFU N/A
- EPS Growth
- SNGX N/A
- WAFU N/A
- EPS
- SNGX N/A
- WAFU N/A
- Revenue
- SNGX $2,342.00
- WAFU $6,374,594.00
- Revenue This Year
- SNGX N/A
- WAFU N/A
- Revenue Next Year
- SNGX N/A
- WAFU N/A
- P/E Ratio
- SNGX N/A
- WAFU N/A
- Revenue Growth
- SNGX N/A
- WAFU N/A
- 52 Week Low
- SNGX $1.09
- WAFU $1.22
- 52 Week High
- SNGX $14.83
- WAFU $7.49
- Technical
- Relative Strength Index (RSI)
- SNGX 34.08
- WAFU 51.69
- Support Level
- SNGX $1.09
- WAFU $1.41
- Resistance Level
- SNGX $1.29
- WAFU $1.53
- Average True Range (ATR)
- SNGX 0.13
- WAFU 0.06
- MACD
- SNGX -0.02
- WAFU 0.01
- Stochastic Oscillator
- SNGX 22.15
- WAFU 54.47
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.